TW200603816A - Risedronate compositions and their methods of use - Google Patents

Risedronate compositions and their methods of use

Info

Publication number: TW200603816A
Authority: TW; Taiwan
Prior art keywords: risedronate; compositions; methods; polymorph; solvate
Prior art date: 2004-07-23

Application number

TW093136901A

Other languages

English (en)

Other versions

TWI351286B (en

Inventor

David Ernest Burgio

Pamela Jean Schofield

Maurice Kent Gately

Jun Shi

Original Assignee

Procter & Gamble

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-07-23

Filing date

2004-11-30

Publication date

2006-02-01

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34958880&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TW200603816(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2004-11-30 Application filed by Procter & Gamble filed Critical Procter & Gamble

2006-02-01 Publication of TW200603816A publication Critical patent/TW200603816A/zh

2011-11-01 Application granted granted Critical

2011-11-01 Publication of TWI351286B publication Critical patent/TWI351286B/zh

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
- A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Physical Education & Sports Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Rheumatology (AREA)
Orthopedic Medicine & Surgery (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

TW093136901A 2004-07-23 2004-11-30 Uses and kits of risedronates TWI351286B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US10/897,897 US20050070504A1 (en)	2001-12-21	2004-07-23	Risedronate compositions and their methods of use

Publications (2)

Publication Number	Publication Date
TW200603816A true TW200603816A (en)	2006-02-01
TWI351286B TWI351286B (en)	2011-11-01

Family

ID=34958880

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
TW093136901A TWI351286B (en)	2004-07-23	2004-11-30	Uses and kits of risedronates

Country Status (20)

Country	Link
US (1)	US20050070504A1 (zh)
EP (1)	EP1776123A1 (zh)
JP (3)	JP5377852B2 (zh)
KR (2)	KR20080083219A (zh)
CN (1)	CN101146542A (zh)
AR (1)	AR046036A1 (zh)
AU (2)	AU2004322703B2 (zh)
BR (1)	BRPI0418973A (zh)
CA (1)	CA2564898A1 (zh)
IL (1)	IL180907A0 (zh)
IS (1)	IS8597A (zh)
MA (1)	MA28778B1 (zh)
MX (1)	MX2007000967A (zh)
NO (1)	NO20071058L (zh)
NZ (1)	NZ552799A (zh)
PE (1)	PE20060144A1 (zh)
RU (1)	RU2007103306A (zh)
TW (1)	TWI351286B (zh)
WO (1)	WO2006022755A1 (zh)
ZA (1)	ZA200701308B (zh)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2002360619B2 (en) *	2001-12-21	2006-10-05	Allergan Pharmaceuticals International Limited	Method for the treatment of bone disorders
KR20090029312A (ko) *	2002-05-10	2009-03-20	에프. 호프만-라 로슈 아게	골다공증 치료 및 예방용 비스포스폰산
SG174628A1 (en) *	2002-12-20	2011-10-28	Hoffmann La Roche	High dose ibandronate formulation
US20080287400A1 (en) *	2004-05-24	2008-11-20	Richard John Dansereau	Low Dosage Forms Of Risedronate Or Its Salts
US20080286359A1 (en) *	2004-05-24	2008-11-20	Richard John Dansereau	Low Dosage Forms Of Risedronate Or Its Salts
AU2011218625B2 (en) *	2004-05-24	2014-03-20	Theramex HQ UK Limited	Dosage forms of risedronate
US7645459B2 (en) *	2004-05-24	2010-01-12	The Procter & Gamble Company	Dosage forms of bisphosphonates
US8071574B2 (en) *	2005-02-22	2011-12-06	John Dennis Bobyn	Implant improving local bone formation
US7473684B2 (en) *	2005-09-16	2009-01-06	Selamine Limited	Bisphosphonate formulation
CA2624897C (en) *	2005-10-12	2017-02-14	Proventiv Therapeutics, Llc	Methods and articles for treating 25-hydroxyvitamin d insufficiency and deficiency
GB0624087D0 (en) *	2006-12-01	2007-01-10	Selamine Ltd	Ramipril combination salt
GB0624090D0 (en) *	2006-12-01	2007-01-10	Selamine Ltd	Ramipril amine salts
GB0624084D0 (en) *	2006-12-01	2007-01-10	Selamine Ltd	Ramipril amino acid salts
KR100844256B1 (ko)	2007-03-23	2008-07-07	코오롱제약주식회사	리세드로네이트와 비타민 ｄ를 포함하는 대사성 골질환치료용 약제조성물 및 이의 제조방법
JP2011529902A (ja) *	2008-07-31	2011-12-15	味の素株式会社	リセドロネートまたはその塩の低投与量形態
KR101379664B1 (ko) *	2008-09-23	2014-04-02	한림제약(주)	리세드론산 또는 그의 염 및 비타민 ｄ를 포함하는 약학 조성물
KR101102364B1 (ko)	2009-09-18	2012-01-03	한림제약(주)	비스포스포네이트 유도체 및 고용량의 콜레칼시페롤을 포함하는 약학 조성물
PT106978A (pt) *	2013-05-31	2014-12-02	Tecnimede Sociedade Tecnico Medicinal S A	Composição sólida oral contendo ácido ibandrónico e vitamina d

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA777769A (en) *	1963-03-18	1968-02-06	H. Roy Clarence	Substituted methylene diphosphonic acid compounds and detergent compositions
IT1201087B (it) *	1982-04-15	1989-01-27	Gentili Ist Spa	Bifosfonati farmacologicamente attivi,procedimento per la loro preparazione e relative composizioni farmaceutiche
FR2531088B1 (fr) *	1982-07-29	1987-08-28	Sanofi Sa	Produits anti-inflammatoires derives de l'acide methylenediphosphonique et leur procede de preparation
IL77243A (en) *	1984-12-21	1996-11-14	Procter & Gamble	Pharmaceutical compositions containing geminal diphosphonic acid compounds and certain such novel compounds
US4761406A (en) *	1985-06-06	1988-08-02	The Procter & Gamble Company	Regimen for treating osteoporosis
DE3623397A1 (de) *	1986-07-11	1988-01-14	Boehringer Mannheim Gmbh	Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
CA1339805C (en) *	1988-01-20	1998-04-07	Yasuo Isomura	(cycloalkylamino)methylenebis(phosphonic acid) and medicines containing the same as an active
CA1336328C (en) *	1988-04-11	1995-07-18	Walter G. Leonard	Method of increasing bone density in humans
US4922007A (en) *	1989-06-09	1990-05-01	Merck & Co., Inc.	Process for preparing 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid or salts thereof
US5227506A (en) *	1989-09-06	1993-07-13	Merck & Co., Inc.	Acyloxymethyl esters of bisphosphonic acids as bone resorption inhibitors
NL8902727A (nl) *	1989-11-06	1991-06-03	Philips Nv	Objecthouder voor ondersteuning van een object in een geladen deeltjesbundelsysteem.
RU2119794C1 (ru) *	1992-06-30	1998-10-10	Проктер энд Гэмбл Фармасьютикалз, Инк.	Использование фосфонатов и нестероидных противовоспалительных лекарственных средств для лечения артрита, способ лечения
US5646134A (en) *	1994-04-21	1997-07-08	Merck & Co., Inc.	Alendronate therapy to prevent loosening of, or pain associated with, orthopedic implant devices
US6008206A (en) *	1994-09-21	1999-12-28	Merck & Co., Inc.	Sodium alendronate preparation for local administration
US6750216B2 (en) *	1996-03-08	2004-06-15	Adolor Corporation	Kappa agonist compounds and pharmaceutical formulations thereof
US5730715A (en) *	1996-06-14	1998-03-24	Becton Dickinson And Company	Method for the iontophoretic administration of bisphosphonates
GB2324726A (en) *	1997-05-01	1998-11-04	Merck & Co Inc	Combination Therapy for the Treatment of Osteoporosis
BR9810027A (pt) *	1997-06-11	2000-09-12	Procter & Gamble	Comprimido revestido por pelìcula para melhorada segurança do trato gastrintestinal superior
US5994329A (en) *	1997-07-22	1999-11-30	Merck & Co., Inc.	Method for inhibiting bone resorption
US6015801A (en) *	1997-07-22	2000-01-18	Merck & Co., Inc.	Method for inhibiting bone resorption
US6432932B1 (en) *	1997-07-22	2002-08-13	Merck & Co., Inc.	Method for inhibiting bone resorption
US6331533B1 (en) *	1998-11-16	2001-12-18	Merck & Co., Inc.	Method for inhibiting dental resorptive lesions
US6225801B1 (en) *	1999-01-14	2001-05-01	Lucent Technologies Inc.	Article comprising electronic circuits and devices with magnetically programmable electrical resistance
JP2001253827A (ja) *	2000-02-15	2001-09-18	Pfizer Prod Inc	骨粗鬆症を治療するための組成物および方法
US6468559B1 (en) *	2000-04-28	2002-10-22	Lipocine, Inc.	Enteric coated formulation of bishosphonic acid compounds and associated therapeutic methods
PL203087B1 (pl) *	2000-06-20	2009-08-31	Novartis Ag	Zastosowanie kwasu 1-hydroksy-2-(imidazol-1-ilo)etano-1,1-difosfonowego albo jego farmaceutycznie dopuszczanej soli albo dowolnego hydratu
US6593310B1 (en) *	2000-11-21	2003-07-15	Arthropharm Pty. Ltd.	Treatment of osteoporosis
AU2002346583A1 (en) *	2001-12-13	2003-06-30	Merck & Co., Inc.	Liquid bisphosphonate formulations for bone disorders
KR20090029312A (ko) *	2002-05-10	2009-03-20	에프. 호프만-라 로슈 아게	골다공증 치료 및 예방용 비스포스폰산
US20040188316A1 (en) *	2003-03-26	2004-09-30	The Procter & Gamble Company	Kit for pharmaceutical use

2004
- 2004-07-23 US US10/897,897 patent/US20050070504A1/en not_active Abandoned
- 2004-09-25 KR KR1020087021196A patent/KR20080083219A/ko not_active Ceased
- 2004-09-25 CA CA002564898A patent/CA2564898A1/en not_active Abandoned
- 2004-09-25 JP JP2007522476A patent/JP5377852B2/ja not_active Expired - Lifetime
- 2004-09-25 AU AU2004322703A patent/AU2004322703B2/en not_active Withdrawn - After Issue
- 2004-09-25 EP EP04789250A patent/EP1776123A1/en not_active Ceased
- 2004-09-25 CN CNA2004800436570A patent/CN101146542A/zh active Pending
- 2004-09-25 KR KR1020077001602A patent/KR20070038115A/ko not_active Ceased
- 2004-09-25 NZ NZ552799A patent/NZ552799A/en not_active IP Right Cessation
- 2004-09-25 RU RU2007103306/14A patent/RU2007103306A/ru unknown
- 2004-09-25 WO PCT/US2004/031975 patent/WO2006022755A1/en not_active Ceased
- 2004-09-25 MX MX2007000967A patent/MX2007000967A/es unknown
- 2004-09-25 BR BRPI0418973-6A patent/BRPI0418973A/pt not_active Application Discontinuation
- 2004-09-29 AR ARP040103537A patent/AR046036A1/es unknown
- 2004-09-30 PE PE2004000960A patent/PE20060144A1/es not_active Application Discontinuation
- 2004-11-30 TW TW093136901A patent/TWI351286B/zh not_active IP Right Cessation
2007
- 2007-01-23 IL IL180907A patent/IL180907A0/en unknown
- 2007-01-24 IS IS8597A patent/IS8597A/is unknown
- 2007-02-01 MA MA29645A patent/MA28778B1/fr unknown
- 2007-02-14 ZA ZA200701308A patent/ZA200701308B/en unknown
- 2007-02-22 NO NO20071058A patent/NO20071058L/no not_active Application Discontinuation
2011
- 2011-03-02 AU AU2011200905A patent/AU2011200905A1/en not_active Abandoned
2013
- 2013-08-16 JP JP2013169220A patent/JP5761274B2/ja not_active Expired - Lifetime
2014
- 2014-10-21 JP JP2014214604A patent/JP5910698B2/ja not_active Expired - Lifetime

Also Published As

Publication number	Publication date
AR046036A1 (es)	2005-11-23
PE20060144A1 (es)	2006-04-17
JP2008507513A (ja)	2008-03-13
NZ552799A (en)	2010-04-30
JP2013231087A (ja)	2013-11-14
RU2007103306A (ru)	2008-09-10
CA2564898A1 (en)	2006-03-02
MX2007000967A (es)	2007-07-11
ZA200701308B (en)	2008-07-30
TWI351286B (en)	2011-11-01
BRPI0418973A (pt)	2007-12-04
JP2015038135A (ja)	2015-02-26
AU2004322703A1 (en)	2006-03-02
WO2006022755A1 (en)	2006-03-02
KR20080083219A (ko)	2008-09-16
IS8597A (is)	2007-01-24
KR20070038115A (ko)	2007-04-09
EP1776123A1 (en)	2007-04-25
AU2004322703B2 (en)	2010-12-02
CN101146542A (zh)	2008-03-19
AU2011200905A1 (en)	2011-03-24
IL180907A0 (en)	2007-07-04
JP5910698B2 (ja)	2016-04-27
MA28778B1 (fr)	2007-08-01
NO20071058L (no)	2007-02-22
JP5377852B2 (ja)	2013-12-25
JP5761274B2 (ja)	2015-08-12
US20050070504A1 (en)	2005-03-31

Publication	Publication Date	Title
NO20071058L (no)	2007-02-22	Risedronatsammensetninger og deres fremgangsmater for anvendelse
WO2013003629A3 (en)	2013-04-11	Methods and compositions for inhibition of bone resorption
MXPA04012998A (es)	2005-05-16	Modulares de receptores nucleares de hormonas esteroideas triciclicos.
NZ594589A (en)	2014-01-31	3h-imidazo [4, 5 -c] pyridine- 6 -carboxamides as anti- inflammatory agents
PT1326613E (pt)	2004-10-29	Utilizacao de derivados de imidazo[1,2-a]piridin-,imidazo[1,2-a]pirimidin- e imidazo[1,2-a]pirazin-3-il-amina substituidos para a fabricacao de medicamentos para inibicao de nos
ES2295609T3 (es)	2008-04-16	Derivados de tiadiazolilpiperazina utiles para tratar o prevenir un dolor.
MY140576A (en)	2009-12-31	Cannabinoid active pharmaceutical ingredient for improved dosage forms
MX340965B (es)	2016-08-02	Combinaciones para el tratamiento de enfermedades que involucran la proliferacion celular.
UA90858C2 (ru)	2010-06-10	Композиция с контролируемым высвобождением варденафила
MY139577A (en)	2009-10-30	Anti-inflammatory androstane derivative
GEP20105025B (en)	2010-06-25	Pharmaceutical compositions for treatent of atherosclerosis and related conditions and use thereof for treatment of these diseases
JP2015038135A5 (zh)	2015-04-09
ATE417615T1 (de)	2009-01-15	Pharmazeutische zusammenstellungen und zubereitungen zur behandlung von stoffwechselbedingten knochenerkrankungen
BRPI0409427A (pt)	2006-04-18	composto, uso do mesmo, composição farmacêutica, método de tratamento de um humano sofrendo de uma doença hiperproliferativa, e, processo para a preparação de um composto ou de um sal, éster ou pró-droga farmaceuticamente aceitáveis do mesmo
SG178975A1 (en)	2012-04-27	Indenone derivative and pharmaceutical composition comprising same
BRPI0411673A (pt)	2006-08-08	composto, sal farmaceuticamente aceitável, composição farmacêutica, e, uso de um composto
EA200870469A1 (ru)	2009-04-28	Новые, содержащие нимесулид, фармацевтические композиции с низкой дозой, их получение и применение
TW200612909A (en)	2006-05-01	Compounds
MX2024014315A (es)	2024-12-06	Compuestos amido heteroaromaticos utiles en el tratamiento de enfermedades hepaticas
PL371264A1 (en)	2005-06-13	Method for the treatment of bone disorders
CA2632207C (en)	2014-12-23	Use of calcitonin for the treatment of ra
MY160429A (en)	2017-03-15	2, 5-disubstituted 3-mercaptopentanoic acid
SE9901572D0 (sv)	1999-05-03	New compounds
UA92498C2 (ru)	2010-11-10	Каннабиноидно активный фармацевтический ингредиент для улучшенных дозированных форм
NZ588470A (en)	2012-12-21	Pharmaceutical composition comprising a benzophenone derivative and an immunosuppressing agent for treating autoimmune diseases

Legal Events

Date	Code	Title	Description
2020-08-01	MM4A	Annulment or lapse of patent due to non-payment of fees